Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Conditions
Multiple Sclerosis, Relapsing-Remitting
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Local Institution - 0114, Loma Linda, California, United States
University of California Davis Health, Sacramento, California, United States
University of South Florida, Tampa, Florida, United States
Local Institution - 0093, Chicago, Illinois, United States
University of Chicago Medical Center, Chicago, Illinois, United States
University of Louisville, Norton Children's Research Institute, Louisville, Kentucky, United States
Local Institution - 0131, New Brunswick, New Jersey, United States
Local Institution - 0132, Teaneck, New Jersey, United States
Local Institution - 0091, Cincinnati, Ohio, United States
Local Institution - 0092, Portland, Oregon, United States
Local Institution - 0133, El Paso, Texas, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Royal Children's Hospital, Melbourne, Victoria, Australia
University of Naples Federico II, Naples, Campania, Italy
Ospedale San Raffaele, Milan, Lombardy, Italy
Local Institution - 0081, Milan, Lombardy, Italy
Neurological Center Of Latium, Rome, Roma, Italy
Local Institution - 0078, Mexico City, DIF, Mexico
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan, Greater Poland Voivodeship, Poland
2Ca Braga, Braga, Portugal
Unidade Local de Saúde de Coimbra, E.P.E., Coimbra, Portugal
Centro Hospitalar de Lisboa Central, Lisbon, Portugal
Local Institution - 0102, Porto, Portugal
Local Institution - 0134, Caguas, Puerto Rico
Spitalul Clinic de Copii Doctor Victor Gomoiu, Bucharest, Bucharest, Romania
Prof. Dr. Alexandru Obregia Psychiatry Hospital, Bucharest, Bucharest, Romania
Local Institution - 0096, Esplugues de Llobregat, Barcelona [Barcelona], Spain
CHUVI- Hospital Alvaro Cunqueiro, Vigo, Pontevedra [Pontevedra], Spain
Hospital Universitario Virgen Macarena, Seville, Spain
Hospital Universitari i Politecnic La Fe, Valencia, Spain
Contact: Study coordinator (Francisco Pérez-Miralles)Hospital Universitario Miguel Servet, Zaragoza, Spain
Contact: Study coordinator (Jesus Martin Martinez)National Taiwan University Hospital, Taipei, Taiwan
Ondokuz Mayıs Universitesi, Samsun, Turkey (Türkiye)
Study leads
Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb